Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)

NCT01103089 · clinicaltrials.gov ↗

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Sponsor

AstraZeneca